Biotechnology company Fate Therapeutics Inc announced that its current cash reserves are sufficient to sustain company operations until the end of 2027.
Show original
The company currently holds a total of $205 million in cash, cash equivalents, and various investments, providing a solid financial foundation for the subsequent development of cell therapies. This financial plan will support the company in advancing multiple preclinical and clinical stage projects, including CAR-NK and iPSC-derived cell therapies, while ensuring sustained investment during critical stages of new drug development.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
The probability of Khamenei stepping down before March 31 surges to 93% on Polymarket
Chaincatcher•2026/02/28 21:20
BTC surpasses $67,000
金色财经•2026/02/28 20:28
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$66,991.6
+2.40%
Ethereum
ETH
$1,966.13
+2.69%
Tether USDt
USDT
$1
+0.02%
XRP
XRP
$1.38
+2.23%
BNB
BNB
$617.37
+1.21%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$84.69
+4.34%
TRON
TRX
$0.2821
-0.18%
Dogecoin
DOGE
$0.09419
+1.53%
Cardano
ADA
$0.2807
+1.75%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now